These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18221031)
1. Tumor stem cell niches: a new functional framework for the action of anticancer drugs. Baguley BC Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):121-7. PubMed ID: 18221031 [TBL] [Abstract][Full Text] [Related]
2. Experimental chemotherapy and concepts related to the cell cycle. Tannock IF Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb; 49(2):335-55. PubMed ID: 3510996 [TBL] [Abstract][Full Text] [Related]
3. [Correlation of stem cell niche to genesis and development of tumor stem cells]. Wu YY; Huang Q; Dong J; Lan Q Ai Zheng; 2008 Jan; 27(1):109-12. PubMed ID: 18184477 [TBL] [Abstract][Full Text] [Related]
4. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065 [TBL] [Abstract][Full Text] [Related]
5. Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells. Saki N; Abroun S; Farshdousti Hagh M; Asgharei F Cell J; 2011; 13(3):131-6. PubMed ID: 23508881 [TBL] [Abstract][Full Text] [Related]
6. The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells. Castaño Z; Fillmore CM; Kim CF; McAllister SS Semin Cancer Biol; 2012 Oct; 22(5-6):462-70. PubMed ID: 22548722 [TBL] [Abstract][Full Text] [Related]
7. The stem cell niche as a pharmaceutical target for prevention of skeletal metastases. Chirgwin JM Anticancer Agents Med Chem; 2012 Mar; 12(3):187-93. PubMed ID: 22044002 [TBL] [Abstract][Full Text] [Related]
8. The stem cell niche in health and malignancy. Burness ML; Sipkins DA Semin Cancer Biol; 2010 Apr; 20(2):107-15. PubMed ID: 20510363 [TBL] [Abstract][Full Text] [Related]
9. Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Miller SJ; Lavker RM; Sun TT Biochim Biophys Acta; 2005 Sep; 1756(1):25-52. PubMed ID: 16139432 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches targeting cancer stem cells. Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025 [TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015). Kharkar PS Expert Opin Ther Pat; 2017 Jul; 27(7):753-761. PubMed ID: 28460551 [TBL] [Abstract][Full Text] [Related]
12. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma. Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521 [TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells: the development of new cancer therapeutics. Scatena R; Bottoni P; Pontoglio A; Giardina B Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158 [TBL] [Abstract][Full Text] [Related]
14. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505 [TBL] [Abstract][Full Text] [Related]
15. Stem cell patents: an innovative approach to anti-cancer drug discovery. Navone S; Cristini S; Canzi L; Parati EA; Invernici G Recent Pat Anticancer Drug Discov; 2010 Jan; 5(1):14-21. PubMed ID: 19601919 [TBL] [Abstract][Full Text] [Related]
16. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Gilbertson RJ; Rich JN Nat Rev Cancer; 2007 Oct; 7(10):733-6. PubMed ID: 17882276 [TBL] [Abstract][Full Text] [Related]
17. [Stem cell niches]. Terskikh VV; Vasil'ev AV; Voroteliak EA Izv Akad Nauk Ser Biol; 2007; (3):261-72. PubMed ID: 17855941 [TBL] [Abstract][Full Text] [Related]
18. [Optimization of the exposure of normal and transformed cell populations to phase-specific agents]. Dibrov BF; Zhabotinskiĭ AM; Neĭfakh IuA; Orlova MP; Churikova LI Biofizika; 1985; 30(6):1050-63. PubMed ID: 4074761 [TBL] [Abstract][Full Text] [Related]